Plus Therapeutics, Inc. (PSTV) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Join SI Premium – FREE
Plus Therapeutics, Inc. (NASDAQ: PSTV) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Plus Therapeutics, Inc. (PSTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Public Service Enterprise (PEG) Misses Q3 EPS by 4c ; Offers Guidance
- Marriott shares rise 3% in premarket trade after raising full-year forecast
- Intrepid Potash (IPI) PT Lowered to $41 at Freedom Broker
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
